TPN at Home: Who Qualifies, How It Works, and What to Expect

June 11, 2026

Total parenteral nutrition (TPN) delivers all the nutrients your body needs, proteins, carbohydrates, fats, vitamins, minerals, and electrolytes, directly into your bloodstream through a central venous catheter. It is prescribed when the gastrointestinal tract cannot absorb nutrition adequately, whether due to disease, surgery, or a structural problem with the bowel.


For many patients, receiving TPN therapy at home is not only possible but clinically appropriate and covered by insurance. Pharmko prepares and delivers personalized TPN formulations to patients across 22+ states, with 24/7 clinical support from first dose through long-term therapy.


Who Qualifies for TPN at Home?


TPN is prescribed when oral nutrition and enteral nutrition (feeding tubes) have been tried or ruled out, and the patient's GI tract cannot provide adequate nutritional support. Common qualifying conditions include:


  • Short bowel syndrome, when significant portions of the small intestine are surgically removed or non-functional
  • Crohn's disease (severe), when active disease or complications prevent adequate absorption
  • Intestinal failure, from obstruction, fistulas, dysmotility, or structural loss
  • Severe pancreatitis requiring prolonged bowel rest
  • Cancer-related GI dysfunction, from the disease itself or from chemotherapy and radiation
  • Post-surgical recovery, when major GI surgery requires extended bowel rest before oral feeding can resume
  • Severe malnutrition with a non-functional GI tract


Your physician or gastroenterologist determines whether TPN is appropriate based on your diagnosis, nutritional status, and clinical course. Most patients are initiated on TPN in a hospital setting and transition to home TPN once they are clinically stable. If you are preparing for that transition, our hospital-to-home guide walks through what to expect at discharge.


How TPN Is Delivered at Home


The central venous catheter


TPN is administered through a central venous catheter (CVC), a thin, flexible tube placed in a large vein, typically near the collarbone, that leads directly toward the heart. Common access devices for home TPN include a PICC line, a tunneled catheter (Hickman or Broviac), or an implanted port. Your physician determines which type is most appropriate based on the expected duration of therapy and your anatomy.


Central line care is one of the most important skills patients and caregivers learn before starting home TPN. Meticulous hygiene and consistent dressing-change technique are the primary defenses against catheter-related bloodstream infections (CLABSI).


The infusion schedule


Most home TPN patients infuse overnight for 10 to 16 hours while sleeping, using a programmable infusion pump that ramps up at the start and tapers at the end of each cycle. This cyclic schedule allows patients to disconnect during the day and maintain normal activity. Some patients with higher caloric needs or specific clinical requirements infuse continuously or in two cycles per day.


The formula


Every TPN formula is custom-compounded by Pharmko's sterile compounding team based on your individual labs, weight, clinical status, and nutritional goals. The formula includes macronutrients (amino acids, dextrose, lipid emulsions) and micronutrients (electrolytes, vitamins, trace minerals). It is reviewed and adjusted regularly based on lab results and clinical changes coordinated by your physician and Pharmko's clinical pharmacist.


What Daily Life Looks Like on Home TPN


Most home TPN patients develop a reliable routine within the first few weeks. The typical daily rhythm involves connecting to the pump in the evening, sleeping through the infusion, disconnecting and flushing the line in the morning, and spending the day disconnected from the pump.


Activities, work, and travel are all possible on home TPN, though each requires some planning. Pharmko delivers your weekly or biweekly supply directly to your home, and our nurses conduct regular visits to assess your line site, review your labs, and address any concerns. Your infusion pump and supplies are provided, set up, and maintained as part of the service.


Insurance Coverage for Home TPN


Home TPN is covered by Medicare Part B, Medicaid, and most commercial insurance plans when it meets medical necessity criteria. Coverage requires documentation of a qualifying GI diagnosis and confirmation that enteral nutrition is not feasible. Pharmko handles prior authorization and insurance coordination for every TPN patient, and we communicate any coverage concerns before therapy begins.


Long-term home TPN can require periodic reauthorization. Our team manages the renewal process proactively so therapy is never interrupted by administrative gaps.


Clinical Monitoring and Safety


Home TPN requires regular lab monitoring, typically weekly at the start, then monthly once stable, to assess liver function, blood glucose, electrolytes, and nutritional markers. Pharmko's clinical pharmacist reviews labs in coordination with your physician and adjusts your formula accordingly.


Know which symptoms should prompt an immediate call during TPN, fever, chills, or redness at the line site can indicate a catheter infection and require same-day assessment. Our after-hours support line is available around the clock.


Contact Pharmko to start a TPN referral: 1-877-540-2003


Myasthenia Gravis and IVIG: What Patients Need to Know About IV Therapy
July 20, 2026
Learn how IVIG therapy works for myasthenia gravis, when it's used, what to expect during infusions, how home IVIG is coordinated, and how Pharmko supports MG patients and their neurologists.
Dobutamine and Inotrope Therapy at Home
July 17, 2026
Learn how home dobutamine infusion works for advanced heart failure, who qualifies, how continuous inotrope therapy is managed at home, and how Pharmko supports cardiac patients and heart failure teams.
CIDP and Home Infusion: IVIG Treatment, Dosing Schedule, and Long-Term Management
July 16, 2026
Learn how IVIG therapy works for CIDP, what the dosing schedule looks like, how to transition to home infusion, and how Pharmko supports long-term CIDP management across 22+ states.
Compounded IV Medications
July 15, 2026
Most medications that patients receive at a hospital or pharmacy come in standardized, commercially manufactured forms, a 500mg antibiotic vial, a pre-filled syringe, a fixed-concentration IV bag. These products work well for many patients. But a significant portion of patients receiving IV therapy have clinical needs that commercial products cannot meet: a dose the manufacturer doesn't make, a formulation incompatible with the patient's allergy profile, or a combination of nutrients that must be tailored to individual lab values. For these patients, compounded IV medications are not optional, they are clinically necessary. Pharmko's sterile compounding services prepare customized IV medications for patients across 22+ states, with every formulation reviewed by a licensed pharmacist and prepared in a USP <797> compliant cleanroom. What Makes an IV Medication 'Compounded'? A compounded medication is one that is prepared specifically for an individual patient by a licensed pharmacist, rather than manufactured in bulk by a pharmaceutical company. Compounding involves combining, mixing, or altering ingredients, active pharmaceutical ingredients, diluents, preservatives, to create a final preparation that meets the patient's unique prescription requirements. For IV therapy specifically, compounding means preparing a sterile preparation, one that is completely free of viable microorganisms and safe to inject or infuse directly into the bloodstream. This requires specialized facilities, equipment, training, and quality systems that go far beyond what a standard retail pharmacy can provide. Pharmko is exclusively a sterile compounding pharmacy. We do not compound oral medications, topical creams, or non-sterile preparations. Every product we make is intended for intravenous, intraperitoneal, or subcutaneous administration. When Are Compounded IV Medications Necessary? The required dose doesn't exist commercially Pharmaceutical manufacturers produce medications in standardized strengths and volumes based on average patient needs. Pediatric patients, patients with renal or hepatic impairment requiring dose adjustments, or patients whose weight or clinical status falls outside standard ranges may need concentrations or volumes that no commercial product provides. Compounding fills this gap precisely. The patient has an allergy to a commercial formulation's inactive ingredients Commercial IV products often contain preservatives, stabilizers, or diluents, sulfites, benzyl alcohol, certain dyes, that some patients cannot tolerate. A compounding pharmacy can prepare an equivalent formulation without the offending ingredient, allowing the patient to receive the therapy safely. The medication requires individualized nutrient formulation Total parenteral nutrition (TPN) is the clearest example: every TPN formula must be individually compounded because no commercial product can provide the precise combination of amino acids, dextrose, lipids, electrolytes, vitamins, and trace minerals a specific patient needs. The formula changes as the patient's labs, weight, and clinical status change, making standardization impossible. The commercial product is unavailable or in shortage Drug shortages are a persistent reality in the US pharmaceutical supply chain. When a commercially manufactured IV medication becomes unavailable, compounding pharmacies can often prepare an equivalent formulation from available active pharmaceutical ingredients, bridging the gap and maintaining continuity of therapy for patients who cannot wait. The therapy requires a custom delivery format Some IV medications require specific pH, osmolarity, or concentration adjustments for compatibility with a patient's IV access device or concurrent medications. A compounding pharmacist reviews compatibility and prepares formulations that are safe and stable for the specific administration route and equipment the patient is using. How Compounded IV Medications Are Made Step 1: Prescription review Every compounded IV medication begins with a valid prescription from a licensed prescriber. Pharmko's pharmacists review the prescription for clinical appropriateness, dosing accuracy, ingredient compatibility, and stability before compounding begins. Step 2: Ingredient sourcing and verification Active pharmaceutical ingredients for compounding must come from FDA-registered suppliers and meet USP monograph specifications. Each lot is verified for identity, potency, and purity before use. Step 3: Sterile preparation in a controlled environment Preparation occurs in an ISO Class 5 laminar airflow workbench or biological safety cabinet, located within a buffer room that meets ISO Class 7 air quality standards. Pharmacy technicians follow validated, written procedures for each preparation type, using aseptic technique to prevent contamination at every step. Step 4: Pharmacist verification and release A licensed pharmacist performs a final check of every preparation, verifying appearance, volume, labeling, and documentation, before the product is released. High-risk or complex preparations may undergo sterility testing with defined beyond-use dates based on test results. Step 5: Cold-chain delivery Most compounded IV medications require refrigeration. Pharmko uses validated cold-chain packaging and delivery logistics to ensure products arrive within their stability windows and remain temperature-controlled until the patient uses them. Quality Standards That Matter Not all compounding pharmacies operate at the same standard. The relevant quality benchmarks for sterile compounding are: USP <797> compliance, the national standard for sterile compounding environments, personnel, and processes. Our guide on USP <797> and USP <800> explains what compliance means in practice ACHC accreditation, independent third-party verification that Pharmko meets clinical quality standards for home infusion and sterile compounding State pharmacy board licensure, Pharmko is licensed in every state where we serve patients Environmental and personnel monitoring, documented air and surface sampling, personnel gowning competency assessments, and media fill testing at defined intervals For a foundational overview of what sterile compounding is and how it differs from retail pharmacy, see our guide on what is sterile compounding for IV therapy . → Contact Pharmko about compounded IV medications: 1-877-540-2003
home infusion therapy Pennsylvania
July 14, 2026
Pharmko provides home infusion therapy across Pennsylvania, IV antibiotics, IVIG, TPN, biologics, and specialty medications. Licensed, ACHC accredited, and available 24/7 statewide.
Home Infusion Therapy in New Jersey
July 14, 2026
Pharmko provides home infusion therapy across New Jersey, IV antibiotics, IVIG, TPN, IDPN, biologics, and more. Licensed, ACHC accredited, and available 24/7 statewide.
Renal dietitian reviewing albumin labs for a peritoneal dialysis patient
July 10, 2026
When to consider IPN for peritoneal dialysis patients with low albumin: clinical criteria, the stepwise nutrition approach, and the referral process.
Nephrologist reviewing dialysis nutrition options for an ESRD patient
July 10, 2026
IPN vs. IDPN explained: how each parenteral nutrition therapy works, who qualifies, and how to choose the right option for ESRD dialysis patients.
How Home Infusion Reduces Hospital Readmissions
July 10, 2026
Home infusion therapy is associated with lower hospital readmission rates, fewer complications, and significant cost savings. Review the clinical evidence and learn how Pharmko supports discharge planning teams.
Primary Immune Deficiency and IVIG: A Guide for Newly Diagnosed Patients
July 8, 2026
Newly diagnosed with primary immune deficiency? Learn how IVIG therapy works, what to expect from your first infusions, how home IVIG is coordinated, and how Pharmko supports PID patients long-term.
Show More